{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:47:17Z","timestamp":1792133237306,"version":"4.4.0"},"reference-count":54,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100020021","name":"Avant Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Res &amp;amp; Perspec"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>This study examined the perceived impacts of New South Wales' (NSW) statewide prescription drug monitoring program (PDMP; \u201cSafeScript NSW\u201d) from the perspective of prescribers and pharmacists, using a qualitative descriptive design. Fourteen prescribers and pharmacists who were users of NSW's PDMP completed semi\u2010structured interviews between May and August 2024. Thematic analysis was guided by the Quadruple Aim framework. Impacts were classified as those relating to (1) population health outcomes, (2) patients' care experience, (3) costs, (4) practitioners' work experience. PDMP's perceived impacts on population health included improved medication safety and reduced prescription shopping. Key patient impacts included risk of stigma and treatment interruption. Despite these, both prescribers and pharmacists reported improved therapeutic relationships with patients following SafeScript NSW use. Impacts on relationships between healthcare practitioners were mixed, with resistance encountered from those who do not use SafeScript NSW. No impacts of PDMP on healthcare delivery costs were reported. Participants discussed efficiency impacts relating to practitioners' work. Both practitioner groups reported PDMP use increased confidence and safer prescribing\/dispensing practices. Workflow misalignment and workarounds were reported, predominantly by pharmacists. This study adds evidence on healthcare practitioners' perspectives on PDMP. To minimize negative impacts, we suggest further evaluation and strategies to address user\u2010identified gaps, including workflow challenges. Collaborative development of system improvements and strategies with users can maximize continued user acceptance and uptake, benefits realization, and the system's long\u2010term success.<\/jats:p>","DOI":"10.1002\/prp2.70326","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:20:03Z","timestamp":1789716003000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impacts of a Statewide Prescription Drug Monitoring Program\u2014Healthcare Practitioner Perspectives"],"prefix":"10.1002","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1947-0267","authenticated-orcid":false,"given":"Emma","family":"Tay","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health The University of Sydney  Sydney New South Wales Australia"},{"name":"Western Sydney Local Health District  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7510-0901","authenticated-orcid":false,"given":"Meredith","family":"Makeham","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health The University of Sydney  Sydney New South Wales Australia"},{"name":"Faculty of Medicine, Health and Human Sciences Macquarie University  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey\u2010Lea","family":"Laba","sequence":"additional","affiliation":[{"name":"Centre for Health Economics Research and Evaluation The University of Technology Sydney  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1645-9126","authenticated-orcid":false,"given":"Melissa","family":"Baysari","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health The University of Sydney  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109887"},{"key":"e_1_2_11_3_1","unstructured":"Australian Commission on Safety and Quality in Health Care \u201cReal\u2010Time Prescription Monitoring \u201d(2025) https:\/\/www.safetyandquality.gov.au\/our\u2010work\/e\u2010health\u2010safety\/real\u2010time\u2010prescription\u2010monitoring."},{"key":"e_1_2_11_4_1","unstructured":"Australian Government Department of Health and Aged Care \u201cNational Real Time Prescription Monitoring \u201d(2025) https:\/\/www.health.gov.au\/our\u2010work\/national\u2010real\u2010time\u2010prescription\u2010monitoring\u2010rtpm."},{"key":"e_1_2_11_5_1","unstructured":"NSW Department of Health \u201cWhat is SafeScript NSW?\u201d(2025) https:\/\/www.health.nsw.gov.au\/pharmaceutical\/safescript\/practitioners\/Pages\/what\u2010is\u2010safescript\u2010nsw.aspx."},{"key":"e_1_2_11_6_1","unstructured":"NSW Department of Health \u201cSafeScript NSW\u2014List of Monitored Medicines \u201d(2024) https:\/\/www.health.nsw.gov.au\/pharmaceutical\/safescript\/Pages\/monitored\u2010medicines.aspx."},{"key":"e_1_2_11_7_1","unstructured":"Australian Government \u201cPoisons Standard October 2021 \u201dhttps:\/\/www.legislation.gov.au\/Details\/F2021L01345."},{"key":"e_1_2_11_8_1","unstructured":"Victoria Department of Health \u201cSafeScript for Prescribers and Pharmacists \u201d(2025) https:\/\/www.health.vic.gov.au\/safescript\/safescript\u2010for\u2010prescribers\u2010and\u2010pharmacists."},{"key":"e_1_2_11_9_1","unstructured":"Tasmania Department of Health \u201cReal Time Prescription Monitoring \u201d(2026) https:\/\/www.health.tas.gov.au\/health\u2010topics\/medicines\u2010and\u2010poisons\u2010regulation\/medicines\u2010and\u2010poisons\u2010regulation\u2010information\u2010health\u2010professionals\/real\u2010time\u2010prescription\u2010monitoring."},{"key":"e_1_2_11_10_1","unstructured":"Queensland Department of Health \u201cQScript and Legislative Requirements \u201d(2026) https:\/\/www.health.qld.gov.au\/clinical\u2010practice\/guidelines\u2010procedures\/medicines\/qscript\/regulating\u2010qscript."},{"key":"e_1_2_11_11_1","unstructured":"South Australia Department of Health \u201cScriptCheckSA for Prescribers and Pharmacists \u201d(2026) https:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/public+content\/sa+health+internet\/clinical+resources\/clinical+programs+and+practice+guidelines\/medicines+and+drugs\/drugs+of+dependence\/scriptchecksa+real+time+prescription+monitoring+in+south+australia\/scriptchecksa+for+prescribers+and+pharmacists."},{"key":"e_1_2_11_12_1","volume-title":"Monitoring and Evaluating Digital Health Interventions: A Practical Guide to Conducting Research and Assessment","author":"World Health Organization","year":"2016"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17062119"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13754"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104053"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15996"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3074"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocag106"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-026-03424-1"},{"issue":"4","key":"e_1_2_11_20_1","first-page":"458","article-title":"Looking for Evidence of Research Impact and Use: A Qualitative Study of an Australian Research\u2010Policy System","volume":"30","author":"Newson R. S.","year":"2021","journal-title":"Research Evaluation"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czaf105"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1713"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2015-004160"},{"key":"e_1_2_11_24_1","unstructured":"E.Tay M.Makeham T. L.Laba J.Raubenheimer andM.Baysari \u201cHealthcare Practitioners' Perceptions and Experiences of a State\u2010Wide Prescription Drug Monitoring Program: A Cross\u2010Sectional Survey \u201dUnder review."},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-11614-8"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/104973239500500201"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-05596-6"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.2196\/16861"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apergo.2021.103498"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43058-025-00790-1"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare14010002"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2011.17.6.430"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12469"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2012.01452.x"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13711"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2015.05.008"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103847"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-15-46"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2018.05.003"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2018.08.006"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2022.100122"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2018.02.009"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2018.06.003"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2013.05.009"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.3109\/15360288.2013.879242"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz289"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2018.09.007"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/14604582241259337"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.1852"},{"key":"e_1_2_11_50_1","first-page":"64","article-title":"Implementation of a Statewide Prescription Drug Monitoring Program \u2010 Healthcare Practitioners' Perspectives","volume":"339","author":"Tay E.","year":"2026","journal-title":"Studies in Health Technology and Informatics"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpdig.2024.11.003"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01662-7"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-0221-y"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108460"},{"key":"e_1_2_11_55_1","volume-title":"National Digital Health Strategy 2023\u20132028","author":"Australian Digital Health Agency","year":"2023"}],"container-title":["Pharmacology Research &amp; Perspectives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.70326","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/prp2.70326","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.70326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:14:56Z","timestamp":1792131296000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/prp2.70326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1002\/prp2.70326"],"URL":"https:\/\/doi.org\/10.1002\/prp2.70326","archive":["Portico"],"relation":{},"ISSN":["2052-1707","2052-1707"],"issn-type":[{"value":"2052-1707","type":"print"},{"value":"2052-1707","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2026-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70326"}}